A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC
Clinical trial NCT05205629 · UNKNOWN
Trial details
- NCT number
- NCT05205629
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-30
- Primary completion
- 2024-01-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.